| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | mRNA splicing, via spliceosome | 1.17e-06 | 358 | 62 | 9 | GO:0000398 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile | 1.17e-06 | 358 | 62 | 9 | GO:0000377 | |
| GeneOntologyBiologicalProcess | RNA splicing, via transesterification reactions | 1.28e-06 | 362 | 62 | 9 | GO:0000375 | |
| GeneOntologyBiologicalProcess | RNA splicing | 1.80e-05 | 502 | 62 | 9 | GO:0008380 | |
| GeneOntologyBiologicalProcess | mRNA processing | 3.73e-05 | 551 | 62 | 9 | GO:0006397 | |
| Domain | BAT2_N | 3.25e-05 | 3 | 62 | 2 | PF07001 | |
| Domain | THRAP3_BCLAF1 | 3.25e-05 | 3 | 62 | 2 | IPR029199 | |
| Domain | THRAP3_BCLAF1 | 3.25e-05 | 3 | 62 | 2 | PF15440 | |
| Domain | BAT2_N | 3.25e-05 | 3 | 62 | 2 | IPR009738 | |
| Domain | PRRC2 | 3.25e-05 | 3 | 62 | 2 | IPR033184 | |
| Domain | PDZ | 1.24e-03 | 141 | 62 | 4 | PF00595 | |
| Domain | Guanylate_kinase_CS | 1.26e-03 | 16 | 62 | 2 | IPR020590 | |
| Domain | PDZ | 1.48e-03 | 148 | 62 | 4 | SM00228 | |
| Domain | - | 1.55e-03 | 150 | 62 | 4 | 2.30.42.10 | |
| Domain | PDZ | 1.59e-03 | 151 | 62 | 4 | PS50106 | |
| Domain | PDZ | 1.63e-03 | 152 | 62 | 4 | IPR001478 | |
| Domain | Nucleotide-bd_a/b_plait | 1.65e-03 | 258 | 62 | 5 | IPR012677 | |
| Domain | GUANYLATE_KINASE_2 | 2.62e-03 | 23 | 62 | 2 | PS50052 | |
| Domain | GUANYLATE_KINASE_1 | 2.62e-03 | 23 | 62 | 2 | PS00856 | |
| Domain | Guanylate_kin | 3.35e-03 | 26 | 62 | 2 | PF00625 | |
| Domain | GK/Ca_channel_bsu | 3.35e-03 | 26 | 62 | 2 | IPR008145 | |
| Domain | Guanylate_kin-like_dom | 3.35e-03 | 26 | 62 | 2 | IPR008144 | |
| Domain | GuKc | 3.35e-03 | 26 | 62 | 2 | SM00072 | |
| Domain | MFS | 5.55e-03 | 108 | 62 | 3 | PS50850 | |
| Domain | RRM | 5.84e-03 | 217 | 62 | 4 | SM00360 | |
| Domain | MFS_sugar_transport-like | 6.35e-03 | 36 | 62 | 2 | IPR005828 | |
| Domain | Sugar_tr | 6.35e-03 | 36 | 62 | 2 | PF00083 | |
| Domain | P-loop_NTPase | 6.74e-03 | 848 | 62 | 8 | IPR027417 | |
| Domain | RRM_dom | 6.84e-03 | 227 | 62 | 4 | IPR000504 | |
| Domain | RRM | 7.15e-03 | 230 | 62 | 4 | PS50102 | |
| Domain | - | 8.77e-03 | 244 | 62 | 4 | 3.30.70.330 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MAGI_PTEN_SIGNALING_PATHWAY | 9.45e-05 | 6 | 36 | 2 | M47523 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | CIRBP SART1 SRSF5 PNN STRBP BCLAF1 EIF4A2 YLPM1 RBM6 HNRNPUL1 LSM14B PRRC2A THRAP3 PRRC2B RBFOX2 | 1.16e-11 | 807 | 63 | 15 | 22681889 |
| Pubmed | New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules. | SRSF5 STRBP EIF4A2 YLPM1 RLIM HNRNPUL1 PLK1 PRRC2A THRAP3 PRRC2B RBFOX2 | 6.68e-10 | 462 | 63 | 11 | 31138677 |
| Pubmed | 1.67e-09 | 274 | 63 | 9 | 34244482 | ||
| Pubmed | SND1 binds SARS-CoV-2 negative-sense RNA and promotes viral RNA synthesis through NSP9. | 2.24e-08 | 258 | 63 | 8 | 37794589 | |
| Pubmed | SART1 SRSF5 PNN STRBP MCM3AP YLPM1 RBM6 KMT2A HNRNPUL1 PRRC2A PRRC2B | 2.39e-08 | 653 | 63 | 11 | 22586326 | |
| Pubmed | SART1 PNN BCLAF1 MCM3AP YLPM1 DNAJB6 GIGYF1 HNRNPUL1 PRRC2A THRAP3 PRRC2B | 2.47e-08 | 655 | 63 | 11 | 35819319 | |
| Pubmed | CIRBP SART1 SRSF5 PNN STRBP BCLAF1 DNAJB6 HNRNPUL1 LSM14B PRRC2A THRAP3 | 5.82e-08 | 713 | 63 | 11 | 29802200 | |
| Pubmed | CIRBP SRSF5 PNN STRBP EIF4A2 MBP RBM6 THRAP3 PRRC2B RBFOX2 METTL14 | 6.70e-08 | 723 | 63 | 11 | 34133714 | |
| Pubmed | CIRBP SART1 SHROOM3 SRSF5 PNN BCLAF1 ZFC3H1 HNRNPUL1 LSM14B PRRC2A THRAP3 | 7.49e-08 | 731 | 63 | 11 | 29298432 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | SART1 INTS5 SRSF5 PNN BCLAF1 YLPM1 RBM6 KMT2A HNRNPUL1 PRRC2A THRAP3 | 1.33e-07 | 774 | 63 | 11 | 15302935 |
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 1.91e-07 | 341 | 63 | 8 | 32971831 | |
| Pubmed | CIRBP ARID3A PNN STRBP YLPM1 RLIM ZBTB10 RBM6 KMT2A GIGYF1 HNRNPUL1 LSM14B PRRC2A PRRC2B | 2.08e-07 | 1429 | 63 | 14 | 35140242 | |
| Pubmed | SART1 SRSF5 PNN BCLAF1 TPRN EIF4A2 YLPM1 DNAJB6 HNRNPUL1 THRAP3 | 2.93e-07 | 660 | 63 | 10 | 32780723 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 2.94e-07 | 361 | 63 | 8 | 26167880 | |
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 2.98e-07 | 148 | 63 | 6 | 32538781 | |
| Pubmed | 3.04e-07 | 244 | 63 | 7 | 29884807 | ||
| Pubmed | CIRBP SART1 INTS5 SRSF5 PNN BCLAF1 ZBTB10 KMT2A ZFC3H1 PRRC2A THRAP3 | 3.25e-07 | 847 | 63 | 11 | 35850772 | |
| Pubmed | CIRBP SART1 ARID3A BCLAF1 KMT2A HNRNPUL1 RUNX2 LSM14B PLK1 PRRC2A THRAP3 PRRC2B | 5.86e-07 | 1103 | 63 | 12 | 34189442 | |
| Pubmed | SART1 PNN BCLAF1 HNRNPUL1 LSM14B PRRC2A THRAP3 PRRC2B RBFOX2 | 6.52e-07 | 551 | 63 | 9 | 34728620 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SART1 NECAP2 STRBP BCLAF1 YLPM1 ZFC3H1 LSM14B PRRC2A THRAP3 PRRC2B | 6.79e-07 | 724 | 63 | 10 | 36232890 |
| Pubmed | Transcription factor protein interactomes reveal genetic determinants in heart disease. | 7.80e-07 | 411 | 63 | 8 | 35182466 | |
| Pubmed | 1.84e-06 | 202 | 63 | 6 | 24639526 | ||
| Pubmed | 2.18e-06 | 115 | 63 | 5 | 17332742 | ||
| Pubmed | Elucidation of the BMI1 interactome identifies novel regulatory roles in glioblastoma. | 2.23e-06 | 329 | 63 | 7 | 34316702 | |
| Pubmed | 2.92e-06 | 491 | 63 | 8 | 36273042 | ||
| Pubmed | Thrap3 promotes osteogenesis by inhibiting the degradation of Runx2. | 3.23e-06 | 2 | 63 | 2 | 35230719 | |
| Pubmed | Co-expression of activin receptor-interacting protein 1 and 2 in mouse nerve cells. | 3.23e-06 | 2 | 63 | 2 | 23523645 | |
| Pubmed | MAGI1 copy number variation in bipolar affective disorder and schizophrenia. | 3.23e-06 | 2 | 63 | 2 | 22381734 | |
| Pubmed | Btf and TRAP150 have distinct roles in regulating subcellular mRNA distribution. | 3.23e-06 | 2 | 63 | 2 | 23778535 | |
| Pubmed | 3.23e-06 | 2 | 63 | 2 | 29112714 | ||
| Pubmed | Fluid shear stress induces Runx-2 expression via upregulation of PIEZO1 in MC3T3-E1 cells. | 3.23e-06 | 2 | 63 | 2 | 32181967 | |
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | 3.24e-06 | 670 | 63 | 9 | 22990118 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.98e-06 | 231 | 63 | 6 | 16452087 | |
| Pubmed | SLC22A9 PRDM10 SRSF5 MCM3AP YLPM1 RLIM MACROD1 KMT2A RASEF CPOX HNRNPUL1 PLK1 | 3.99e-06 | 1327 | 63 | 12 | 32694731 | |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 4.11e-06 | 361 | 63 | 7 | 30344098 | |
| Pubmed | CIRBP MAGI1 SRSF5 PNN DNAJB6 RBM6 KMT2A PRRC2A ARHGEF15 RBFOX2 | 5.53e-06 | 916 | 63 | 10 | 32203420 | |
| Pubmed | 6.41e-06 | 251 | 63 | 6 | 31076518 | ||
| Pubmed | 6.62e-06 | 549 | 63 | 8 | 38280479 | ||
| Pubmed | 7.30e-06 | 68 | 63 | 4 | 29091030 | ||
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 7.45e-06 | 558 | 63 | 8 | 27591049 | |
| Pubmed | 7.74e-06 | 69 | 63 | 4 | 35264565 | ||
| Pubmed | 7.84e-06 | 260 | 63 | 6 | 36199071 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART1 PNN STRBP BCLAF1 YLPM1 RBM6 KMT2A HNRNPUL1 PRRC2A THRAP3 | 7.88e-06 | 954 | 63 | 10 | 36373674 |
| Pubmed | 8.51e-06 | 22 | 63 | 3 | 38507412 | ||
| Pubmed | SART1 MAGI1 MAGI2 SHROOM3 BCLAF1 EIF4A2 YLPM1 PRRC2A THRAP3 PRRC2B | 8.55e-06 | 963 | 63 | 10 | 28671696 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | 8.85e-06 | 759 | 63 | 9 | 35915203 | |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 9.11e-06 | 154 | 63 | 5 | 16055720 | |
| Pubmed | SART1 PNN STRBP BCLAF1 EIF4A2 YLPM1 DNAJB6 KMT2A ZFC3H1 CPOX THRAP3 PRRC2B | 9.26e-06 | 1442 | 63 | 12 | 35575683 | |
| Pubmed | 9.68e-06 | 3 | 63 | 2 | 28536481 | ||
| Pubmed | RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis. | 9.68e-06 | 3 | 63 | 2 | 34006870 | |
| Pubmed | Analysis of regulatory polymorphisms in organic ion transporter genes (SLC22A) in the kidney. | 9.68e-06 | 3 | 63 | 2 | 18414781 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 1.01e-05 | 582 | 63 | 8 | 20467437 | |
| Pubmed | A bead-based approach for large-scale identification of in vitro kinase substrates. | 1.20e-05 | 163 | 63 | 5 | 22113938 | |
| Pubmed | 1.27e-05 | 601 | 63 | 8 | 33658012 | ||
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 1.34e-05 | 605 | 63 | 8 | 28977666 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | SART1 INTS5 SRSF5 PNN BCLAF1 YLPM1 KMT2A ZFC3H1 HNRNPUL1 THRAP3 RBFOX2 | 1.89e-05 | 1294 | 63 | 11 | 30804502 |
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 15037815 | ||
| Pubmed | 1.93e-05 | 4 | 63 | 2 | 19417012 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CIRBP SART1 INTS5 SRSF5 PNN BCLAF1 YLPM1 RBM6 HNRNPUL1 THRAP3 | 2.33e-05 | 1082 | 63 | 10 | 38697112 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | 2.40e-05 | 861 | 63 | 9 | 36931259 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | 2.81e-05 | 486 | 63 | 7 | 30940648 | |
| Pubmed | The dynamic interactome of human Aha1 upon Y223 phosphorylation. | 2.87e-05 | 96 | 63 | 4 | 26693507 | |
| Pubmed | Dynamic protein-protein interaction wiring of the human spliceosome. | 2.98e-05 | 197 | 63 | 5 | 22365833 | |
| Pubmed | CIRBP SRSF5 STRBP BCLAF1 MCM3AP YLPM1 KMT2A LSM14B PRRC2A THRAP3 PRRC2B | 3.21e-05 | 1371 | 63 | 11 | 36244648 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 18794151 | ||
| Pubmed | PLK1-dependent activation of LRRK1 regulates spindle orientation by phosphorylating CDK5RAP2. | 3.22e-05 | 5 | 63 | 2 | 26192437 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 23121087 | ||
| Pubmed | Evaluation of genetic susceptibility loci for obesity in Chinese women. | 3.22e-05 | 5 | 63 | 2 | 20616199 | |
| Pubmed | 3.22e-05 | 5 | 63 | 2 | 21144847 | ||
| Pubmed | Rewiring of RSK-PDZ Interactome by Linear Motif Phosphorylation. | 3.26e-05 | 34 | 63 | 3 | 30726710 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 3.69e-05 | 910 | 63 | 9 | 36736316 | |
| Pubmed | Quantifying domain-ligand affinities and specificities by high-throughput holdup assay. | 3.88e-05 | 36 | 63 | 3 | 26053890 | |
| Pubmed | 4.05e-05 | 210 | 63 | 5 | 16565220 | ||
| Pubmed | 4.07e-05 | 105 | 63 | 4 | 9628581 | ||
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 4.34e-05 | 714 | 63 | 8 | 28302793 | |
| Pubmed | Large-scale identification of mammalian proteins localized to nuclear sub-compartments. | 4.57e-05 | 38 | 63 | 3 | 11555636 | |
| Pubmed | USP31 MAGI2 SRSF5 BCLAF1 AJM1 MBP DNAJB6 KMT2A PRRC2A THRAP3 PRRC2B | 4.73e-05 | 1431 | 63 | 11 | 37142655 | |
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 24100041 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 15509766 | ||
| Pubmed | 4.82e-05 | 6 | 63 | 2 | 25503564 | ||
| Pubmed | Atrophin-1, the DRPLA gene product, interacts with two families of WW domain-containing proteins. | 4.82e-05 | 6 | 63 | 2 | 9647693 | |
| Pubmed | Genome-scale RNAi screen for host factors required for HIV replication. | 4.95e-05 | 361 | 63 | 6 | 18976975 | |
| Pubmed | 5.38e-05 | 223 | 63 | 5 | 20020773 | ||
| Pubmed | 5.62e-05 | 114 | 63 | 4 | 31553912 | ||
| Pubmed | 6.36e-05 | 754 | 63 | 8 | 35906200 | ||
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 7.00e-05 | 989 | 63 | 9 | 36424410 | |
| Pubmed | 7.03e-05 | 236 | 63 | 5 | 36339263 | ||
| Pubmed | 8.03e-05 | 1007 | 63 | 9 | 34597346 | ||
| Pubmed | 8.47e-05 | 1014 | 63 | 9 | 32416067 | ||
| Pubmed | PROTAC-mediated degradation reveals a non-catalytic function of AURORA-A kinase. | 8.72e-05 | 247 | 63 | 5 | 32989298 | |
| Pubmed | Alternative splicing, gene localization, and binding of SH2-B to the insulin receptor kinase domain. | 8.98e-05 | 8 | 63 | 2 | 10594240 | |
| Pubmed | Proteomic analysis of beta1-adrenergic receptor interactions with PDZ scaffold proteins. | 8.98e-05 | 8 | 63 | 2 | 16316992 | |
| Pubmed | SR protein-specific kinase 1 is highly expressed in testis and phosphorylates protamine 1. | 8.98e-05 | 8 | 63 | 2 | 10390541 | |
| Pubmed | 1.23e-04 | 615 | 63 | 7 | 31048545 | ||
| Pubmed | 1.28e-04 | 268 | 63 | 5 | 33640491 | ||
| Pubmed | TRIM28-mediated nucleocapsid protein SUMOylation enhances SARS-CoV-2 virulence. | 1.29e-04 | 430 | 63 | 6 | 38172120 | |
| Pubmed | Control of a neuronal morphology program by an RNA-binding zinc finger protein, Unkempt. | 1.35e-04 | 271 | 63 | 5 | 25737280 | |
| Pubmed | 1.37e-04 | 272 | 63 | 5 | 31010829 | ||
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 1.46e-04 | 440 | 63 | 6 | 34244565 | |
| Pubmed | The PRMT5/WDR77 complex regulates alternative splicing through ZNF326 in breast cancer. | 1.50e-04 | 147 | 63 | 4 | 28977470 | |
| Interaction | ATN1 interactions | 1.04e-07 | 187 | 62 | 8 | int:ATN1 | |
| Interaction | SNRPA interactions | CIRBP SART1 PNN BCLAF1 YLPM1 RBM6 GIGYF1 ZFC3H1 HNRNPUL1 THRAP3 RBFOX2 | 2.21e-07 | 482 | 62 | 11 | int:SNRPA |
| Interaction | GLDC interactions | 5.70e-07 | 321 | 62 | 9 | int:GLDC | |
| Interaction | BMI1 interactions | CIRBP STRBP BCLAF1 YLPM1 RBM6 KMT2A HNRNPUL1 LSM14B PRRC2A THRAP3 PRRC2B RBFOX2 | 6.54e-07 | 659 | 62 | 12 | int:BMI1 |
| Interaction | DDX21 interactions | SART1 SRSF5 PNN STRBP BCLAF1 YLPM1 RLIM MACROD1 RUNX2 THRAP3 RBFOX2 METTL14 | 1.61e-06 | 718 | 62 | 12 | int:DDX21 |
| Interaction | MYCN interactions | CIRBP SART1 SHROOM3 SRSF5 PNN STRBP BCLAF1 RBM6 KMT2A ZFC3H1 HNRNPUL1 LSM14B PRRC2A THRAP3 PRRC2B RBFOX2 | 2.70e-06 | 1373 | 62 | 16 | int:MYCN |
| Interaction | FUS interactions | SART1 SRSF5 PNN STRBP BCLAF1 YLPM1 RLIM RBM6 HNRNPUL1 PRRC2A THRAP3 METTL14 | 2.78e-06 | 757 | 62 | 12 | int:FUS |
| Interaction | FUBP3 interactions | 3.43e-06 | 297 | 62 | 8 | int:FUBP3 | |
| Interaction | PRMT1 interactions | CIRBP SART1 PNN BCLAF1 MBP YLPM1 HNRNPUL1 LSM14B PRRC2A THRAP3 PRRC2B RBFOX2 METTL14 | 3.97e-06 | 929 | 62 | 13 | int:PRMT1 |
| Interaction | CPEB1 interactions | 5.74e-06 | 146 | 62 | 6 | int:CPEB1 | |
| Interaction | H2BC12 interactions | 6.22e-06 | 322 | 62 | 8 | int:H2BC12 | |
| Interaction | SMG6 interactions | 6.35e-06 | 85 | 62 | 5 | int:SMG6 | |
| Interaction | CD2BP2 interactions | 7.03e-06 | 232 | 62 | 7 | int:CD2BP2 | |
| Interaction | RNF113A interactions | SART1 PNN BCLAF1 MCM3AP YLPM1 DNAJB6 GIGYF1 HNRNPUL1 PRRC2A THRAP3 PRRC2B | 7.45e-06 | 692 | 62 | 11 | int:RNF113A |
| Interaction | MEN1 interactions | SART1 SRSF5 PNN BCLAF1 MCM3AP YLPM1 ZBTB10 KMT2A ZFC3H1 RUNX2 PLK1 PRRC2A THRAP3 | 1.20e-05 | 1029 | 62 | 13 | int:MEN1 |
| Interaction | ZC3H18 interactions | CIRBP SART1 SHROOM3 SRSF5 PNN BCLAF1 RBM6 ZFC3H1 HNRNPUL1 LSM14B PRRC2A THRAP3 | 1.24e-05 | 877 | 62 | 12 | int:ZC3H18 |
| Interaction | PPP1CC interactions | SRSF5 PNN BCLAF1 TPRN YLPM1 RLIM ZBTB10 ZFC3H1 HNRNPUL1 PLK1 THRAP3 | 1.36e-05 | 738 | 62 | 11 | int:PPP1CC |
| Interaction | SIRT7 interactions | SART1 SRSF5 PNN STRBP MCM3AP YLPM1 RBM6 KMT2A HNRNPUL1 PRRC2A PRRC2B | 1.47e-05 | 744 | 62 | 11 | int:SIRT7 |
| Interaction | KIF20A interactions | SART1 SHROOM3 SRSF5 PNN BCLAF1 EIF4A2 YLPM1 LRRK1 HNRNPUL1 PRRC2A THRAP3 PRRC2B RBFOX2 | 1.51e-05 | 1052 | 62 | 13 | int:KIF20A |
| Interaction | CEBPA interactions | CIRBP SART1 ARID3A SRSF5 PNN BCLAF1 KMT2A HNRNPUL1 RUNX2 LSM14B PLK1 PRRC2A THRAP3 PRRC2B | 1.94e-05 | 1245 | 62 | 14 | int:CEBPA |
| Interaction | SF3A2 interactions | 2.02e-05 | 273 | 62 | 7 | int:SF3A2 | |
| Interaction | SNRNP40 interactions | SART1 PRDM10 PNN STRBP BCLAF1 RBM6 KMT2A ZFC3H1 HNRNPUL1 RBFOX2 | 2.26e-05 | 637 | 62 | 10 | int:SNRNP40 |
| Interaction | HNRNPA1 interactions | CIRBP PNN STRBP BCLAF1 EIF4A2 YLPM1 RBM6 HNRNPUL1 PRRC2A PRRC2B RBFOX2 METTL14 | 2.60e-05 | 945 | 62 | 12 | int:HNRNPA1 |
| Interaction | SNRPB interactions | 2.72e-05 | 517 | 62 | 9 | int:SNRPB | |
| Interaction | DHX8 interactions | 3.10e-05 | 292 | 62 | 7 | int:DHX8 | |
| Interaction | SRSF4 interactions | 3.69e-05 | 300 | 62 | 7 | int:SRSF4 | |
| Interaction | EIF4ENIF1 interactions | 3.69e-05 | 300 | 62 | 7 | int:EIF4ENIF1 | |
| Interaction | SNRNP70 interactions | CIRBP SART1 SRSF5 PNN STRBP BCLAF1 DNAJB6 HNRNPUL1 LSM14B PRRC2A THRAP3 METTL14 | 3.87e-05 | 984 | 62 | 12 | int:SNRNP70 |
| Interaction | NUPR1 interactions | SART1 SRSF5 PNN BCLAF1 TPRN EIF4A2 YLPM1 DNAJB6 HNRNPUL1 THRAP3 | 4.09e-05 | 683 | 62 | 10 | int:NUPR1 |
| Interaction | SSRP1 interactions | SART1 PNN BCLAF1 YLPM1 MACROD1 DNAJB6 KMT2A ZFC3H1 PRRC2A THRAP3 | 4.20e-05 | 685 | 62 | 10 | int:SSRP1 |
| Interaction | HDLBP interactions | CIRBP SRSF5 PNN STRBP MCM3AP YLPM1 DNAJB6 KMT2A PRRC2A THRAP3 METTL14 | 5.26e-05 | 855 | 62 | 11 | int:HDLBP |
| Interaction | FAM53C interactions | 5.71e-05 | 68 | 62 | 4 | int:FAM53C | |
| Interaction | MAPKAPK2 interactions | 5.76e-05 | 134 | 62 | 5 | int:MAPKAPK2 | |
| Interaction | DDX39B interactions | 5.80e-05 | 570 | 62 | 9 | int:DDX39B | |
| Interaction | SNRPC interactions | 5.83e-05 | 440 | 62 | 8 | int:SNRPC | |
| Interaction | RBM42 interactions | 6.86e-05 | 331 | 62 | 7 | int:RBM42 | |
| Interaction | CDK12 interactions | 7.11e-05 | 228 | 62 | 6 | int:CDK12 | |
| Interaction | HDAC7 interactions | 7.33e-05 | 141 | 62 | 5 | int:HDAC7 | |
| Interaction | ASB18 interactions | 7.69e-05 | 27 | 62 | 3 | int:ASB18 | |
| Interaction | PUM2 interactions | 8.10e-05 | 144 | 62 | 5 | int:PUM2 | |
| Interaction | HDAC4 interactions | MAGI1 KSR1 STRBP TMEM121B DNAJB6 GIGYF1 RUNX2 PRRC2A THRAP3 PRRC2B | 8.37e-05 | 744 | 62 | 10 | int:HDAC4 |
| Interaction | SNW1 interactions | SART1 SHROOM3 SRSF5 PNN RBM6 KMT2A HNRNPUL1 RUNX2 PLK1 RBFOX2 | 8.66e-05 | 747 | 62 | 10 | int:SNW1 |
| Interaction | LUC7L interactions | 9.87e-05 | 242 | 62 | 6 | int:LUC7L | |
| Interaction | SRPK1 interactions | 1.02e-04 | 477 | 62 | 8 | int:SRPK1 | |
| Interaction | YTHDF3 interactions | 1.08e-04 | 246 | 62 | 6 | int:YTHDF3 | |
| Interaction | HDAC11 interactions | 1.11e-04 | 154 | 62 | 5 | int:HDAC11 | |
| Interaction | DHX40 interactions | 1.15e-04 | 249 | 62 | 6 | int:DHX40 | |
| Interaction | LSM14A interactions | 1.46e-04 | 260 | 62 | 6 | int:LSM14A | |
| Interaction | SRSF6 interactions | 1.48e-04 | 503 | 62 | 8 | int:SRSF6 | |
| Interaction | LGR4 interactions | 1.52e-04 | 262 | 62 | 6 | int:LGR4 | |
| Interaction | H2AC4 interactions | 1.54e-04 | 506 | 62 | 8 | int:H2AC4 | |
| Interaction | SNRPF interactions | 1.75e-04 | 385 | 62 | 7 | int:SNRPF | |
| Interaction | PRMT2 interactions | 1.78e-04 | 91 | 62 | 4 | int:PRMT2 | |
| Interaction | HECTD1 interactions | SART1 SHROOM3 SRSF5 PNN STRBP EIF4A2 RBM6 ZFC3H1 HNRNPUL1 PLK1 PRRC2A | 1.83e-04 | 984 | 62 | 11 | int:HECTD1 |
| Interaction | RERE interactions | 1.93e-04 | 93 | 62 | 4 | int:RERE | |
| Interaction | CPSF6 interactions | 2.00e-04 | 526 | 62 | 8 | int:CPSF6 | |
| Interaction | TNRC6A interactions | 2.18e-04 | 280 | 62 | 6 | int:TNRC6A | |
| Interaction | NEIL3 interactions | 2.27e-04 | 97 | 62 | 4 | int:NEIL3 | |
| Interaction | CELF1 interactions | 2.54e-04 | 288 | 62 | 6 | int:CELF1 | |
| Interaction | GATA4 interactions | 2.61e-04 | 411 | 62 | 7 | int:GATA4 | |
| Interaction | RBM14 interactions | 2.81e-04 | 553 | 62 | 8 | int:RBM14 | |
| Interaction | UBAP2L interactions | 3.05e-04 | 298 | 62 | 6 | int:UBAP2L | |
| Interaction | KLF5 interactions | 3.33e-04 | 195 | 62 | 5 | int:KLF5 | |
| Interaction | RPS16 interactions | PRDM10 SRSF5 STRBP EIF4A2 RLIM HNRNPUL1 PRRC2A PRRC2B METTL14 | 3.50e-04 | 724 | 62 | 9 | int:RPS16 |
| Interaction | YWHAG interactions | USP31 MAGI1 KSR1 SHROOM3 PNN BCLAF1 DNAJB6 KMT2A GIGYF1 HNRNPUL1 PLK1 THRAP3 | 3.64e-04 | 1248 | 62 | 12 | int:YWHAG |
| Interaction | CIT interactions | SART1 MAGI1 INTS5 SRSF5 PNN STRBP BCLAF1 TPRN EIF4A2 KMT2A HNRNPUL1 PRRC2A THRAP3 | 3.92e-04 | 1450 | 62 | 13 | int:CIT |
| Interaction | MAP3K21 interactions | 3.93e-04 | 112 | 62 | 4 | int:MAP3K21 | |
| Interaction | MELK interactions | 3.93e-04 | 112 | 62 | 4 | int:MELK | |
| Interaction | OBSL1 interactions | CIRBP SART1 SHROOM3 INTS5 PNN STRBP BCLAF1 YLPM1 HNRNPUL1 THRAP3 | 3.98e-04 | 902 | 62 | 10 | int:OBSL1 |
| Interaction | SRSF11 interactions | 4.01e-04 | 203 | 62 | 5 | int:SRSF11 | |
| Interaction | PABPC4 interactions | 4.05e-04 | 442 | 62 | 7 | int:PABPC4 | |
| Interaction | TRIB2 interactions | 4.08e-04 | 47 | 62 | 3 | int:TRIB2 | |
| Interaction | TSSK6 interactions | 4.08e-04 | 47 | 62 | 3 | int:TSSK6 | |
| Interaction | APEX1 interactions | CIRBP ARID3A SRSF5 STRBP EIF4A2 DNAJB6 KMT2A HNRNPUL1 PLK1 PRRC2A THRAP3 METTL14 | 4.29e-04 | 1271 | 62 | 12 | int:APEX1 |
| Interaction | SMG7 interactions | 4.38e-04 | 319 | 62 | 6 | int:SMG7 | |
| Interaction | BARD1 interactions | 4.68e-04 | 323 | 62 | 6 | int:BARD1 | |
| Interaction | CAMKV interactions | 4.79e-04 | 118 | 62 | 4 | int:CAMKV | |
| Interaction | RBM6 interactions | 4.95e-04 | 119 | 62 | 4 | int:RBM6 | |
| Interaction | XRCC6 interactions | SART1 STRBP BCLAF1 YLPM1 RLIM MACROD1 KMT2A RUNX2 THRAP3 METTL14 | 4.97e-04 | 928 | 62 | 10 | int:XRCC6 |
| Interaction | ACER3 interactions | 5.03e-04 | 11 | 62 | 2 | int:ACER3 | |
| Interaction | PRP4K interactions | 5.15e-04 | 329 | 62 | 6 | int:PRP4K | |
| Interaction | CLK1 interactions | 5.66e-04 | 219 | 62 | 5 | int:CLK1 | |
| Interaction | ANKRD34A interactions | 5.82e-04 | 53 | 62 | 3 | int:ANKRD34A | |
| Interaction | UQCR11 interactions | 5.82e-04 | 53 | 62 | 3 | int:UQCR11 | |
| Interaction | PARP1 interactions | SART1 MAGI1 ARID3A PNN STRBP RLIM MACROD1 DNAJB6 ZBTB10 HNRNPUL1 THRAP3 METTL14 | 5.86e-04 | 1316 | 62 | 12 | int:PARP1 |
| Interaction | SF3A1 interactions | 5.91e-04 | 471 | 62 | 7 | int:SF3A1 | |
| Interaction | OASL interactions | 6.15e-04 | 223 | 62 | 5 | int:OASL | |
| Interaction | ARRDC3 interactions | 6.27e-04 | 224 | 62 | 5 | int:ARRDC3 | |
| Interaction | H3C6 interactions | 6.53e-04 | 226 | 62 | 5 | int:H3C6 | |
| Interaction | SH3RF3 interactions | 6.84e-04 | 56 | 62 | 3 | int:SH3RF3 | |
| Interaction | GAB2 interactions | 6.90e-04 | 130 | 62 | 4 | int:GAB2 | |
| Interaction | HNRNPC interactions | 6.94e-04 | 634 | 62 | 8 | int:HNRNPC | |
| Interaction | BRD7 interactions | 7.16e-04 | 637 | 62 | 8 | int:BRD7 | |
| Interaction | KSR1 interactions | 7.31e-04 | 132 | 62 | 4 | int:KSR1 | |
| Interaction | PRNP interactions | CIRBP MAGI1 MAGI2 KSR1 NECAP2 TPRN EIF4A2 MBP RLIM GIGYF1 PRRC2B | 7.31e-04 | 1158 | 62 | 11 | int:PRNP |
| Interaction | DOT1L interactions | 7.65e-04 | 807 | 62 | 9 | int:DOT1L | |
| Interaction | EIF4A3 interactions | 8.30e-04 | 499 | 62 | 7 | int:EIF4A3 | |
| Interaction | TBC1D25 interactions | 8.37e-04 | 60 | 62 | 3 | int:TBC1D25 | |
| Interaction | LARP4B interactions | 8.56e-04 | 240 | 62 | 5 | int:LARP4B | |
| Interaction | MATR3 interactions | 8.58e-04 | 655 | 62 | 8 | int:MATR3 | |
| Cytoband | 16p12.2 | 1.20e-03 | 37 | 63 | 2 | 16p12.2 | |
| Cytoband | 11q11 | 1.93e-03 | 47 | 63 | 2 | 11q11 | |
| Cytoband | 16q24.3 | 2.35e-03 | 52 | 63 | 2 | 16q24.3 | |
| Cytoband | 3p21.3 | 3.02e-03 | 59 | 63 | 2 | 3p21.3 | |
| Cytoband | 11q13.1 | 3.43e-03 | 63 | 63 | 2 | 11q13.1 | |
| Cytoband | 19p13.3 | 4.29e-03 | 237 | 63 | 3 | 19p13.3 | |
| GeneFamily | PDZ domain containing | 3.47e-04 | 152 | 40 | 4 | 1220 | |
| GeneFamily | RNA binding motif containing | 1.23e-03 | 213 | 40 | 4 | 725 | |
| GeneFamily | Calcium voltage-gated channel subunits|Membrane associated guanylate kinases | 1.50e-03 | 26 | 40 | 2 | 904 | |
| GeneFamily | Actins|Deafness associated genes | 1.98e-03 | 113 | 40 | 3 | 1152 | |
| Coexpression | GSE6259_BCELL_VS_CD4_TCELL_UP | 6.86e-06 | 192 | 63 | 6 | M6732 | |
| Coexpression | GSE17721_POLYIC_VS_GARDIQUIMOD_1H_BMDC_UP | 8.66e-06 | 200 | 63 | 6 | M4016 | |
| ToppCell | facs-Heart-RA-18m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-07 | 178 | 63 | 6 | b505e2550860e777535ee95f29c936242fd607f1 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.28e-06 | 184 | 63 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | ILEUM-inflamed-(3)_MNP-(3)_pDC|(3)_MNP / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.45e-06 | 185 | 63 | 5 | 308a98f111895071d8772bc010554471cc12fab2 | |
| ToppCell | myeloid-pDC|myeloid / Lineage and Cell class | 6.97e-06 | 188 | 63 | 5 | a2dc4bbeca2bdc00c51825dd65a699c54c72f241 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 7.16e-06 | 189 | 63 | 5 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | COVID-19_Severe-pDC|COVID-19_Severe / disease group, cell group and cell class | 7.34e-06 | 190 | 63 | 5 | c5ab6b7492fb86aff3d2af3eb671c9f985ae4aeb | |
| ToppCell | 3'_v3-Lung-Lymphocytic_NK-NK_CD56bright_CD16-|Lung / Manually curated celltypes from each tissue | 7.53e-06 | 191 | 63 | 5 | 12ce360dc149c85d5a22cfc1bf53d54aef79edc1 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 7.72e-06 | 192 | 63 | 5 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.75e-06 | 197 | 63 | 5 | ef2d1f56acd0be43e69bba7f73f6909ba87f1cb3 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-pDC|COVID-19_Severe / Disease, condition lineage and cell class | 8.97e-06 | 198 | 63 | 5 | 033ed362333e1d33f2aeea8da5865d2228d154dc | |
| ToppCell | MS-Multiple_Sclerosis-Myeloid-pDC|Multiple_Sclerosis / Disease, condition lineage and cell class | 9.19e-06 | 199 | 63 | 5 | c10c8c9322cad4996e4aa11a8680e3d781644ace | |
| ToppCell | COVID-19-COVID-19_Mild-Myeloid-pDC|COVID-19_Mild / Disease, condition lineage and cell class | 9.19e-06 | 199 | 63 | 5 | 9de61e5189d907cc969ac3043d68204f70acc0bf | |
| ToppCell | primary_visual_cortex|World / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.77e-05 | 141 | 63 | 4 | 605d7b28e99c943f64b4095855a6f9f70e92cb09 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_NOS-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 7.61e-05 | 159 | 63 | 4 | c40fe552da3abdb1df87e9e1647468dc038bec0a | |
| ToppCell | Endothelial-endothelial_cell_of_bronchial_vessel|World / Lineage, Cell type, age group and donor | 8.78e-05 | 165 | 63 | 4 | 84e553d699ac56df89a77248f7308b9133e1b683 | |
| ToppCell | normal_Lymph_Node-B_lymphocytes-GrB-secreting_B_cells|normal_Lymph_Node / Location, Cell class and cell subclass | 1.10e-04 | 175 | 63 | 4 | 29fbdfe1d3bfcb063be2bced0128a33176c5b78f | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 176 | 63 | 4 | 8e89471f838ea81235256cc2470f1c12c9b75f8a | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 176 | 63 | 4 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | moderate-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.23e-04 | 180 | 63 | 4 | 1d8df7df03a71f49d6683554d3c948ce90dda42e | |
| ToppCell | NS-moderate-d_16-33-Myeloid-pDC|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.23e-04 | 180 | 63 | 4 | 144818e69613296cde43f29cb8c20899c670b319 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-pDC|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.25e-04 | 181 | 63 | 4 | 60607c5ff6d5b1cb416adc034491dca31c41e988 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 183 | 63 | 4 | 764ea07621f77fbd13a877aed5806ae2b3dfb43e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.31e-04 | 183 | 63 | 4 | c5e90577b57a86c06afdf89d4b519b3694f813f9 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.31e-04 | 183 | 63 | 4 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | normal_Lung-B_lymphocytes-GrB-secreting_B_cells|normal_Lung / Location, Cell class and cell subclass | 1.31e-04 | 183 | 63 | 4 | c930b957d16f9b0904b6c424acd914532e5cc137 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|World / Lineage, cell class and subclass | 1.34e-04 | 184 | 63 | 4 | 11619778bc773ecd1a9867330be04deaf324f31e | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 1.36e-04 | 185 | 63 | 4 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|Dendritic_cell / Lineage, cell class and subclass | 1.39e-04 | 186 | 63 | 4 | 858134580a09ed8a5eb6d6413d8ca9265904dfc1 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.39e-04 | 186 | 63 | 4 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.39e-04 | 186 | 63 | 4 | 2ea5ff14861e5f91d0e6a5767c403a24045d715c | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.39e-04 | 186 | 63 | 4 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Control-Epithelial-ATII|World / Disease state, Lineage and Cell class | 1.39e-04 | 186 | 63 | 4 | f4b6e401e19a71beddc73d8a1e08359f7c4025cf | |
| ToppCell | (0)_Myeloid-(01)_Dendritic_cell-(011)_pDC|(01)_Dendritic_cell / immune cells in Peripheral Blood (logTPM normalization) | 1.42e-04 | 187 | 63 | 4 | 068502efa3f0ac4cea2fa4a18d1c2f686a4fba54 | |
| ToppCell | LAM-Lymphoid-pDC|Lymphoid / Condition, Lineage and Cell class | 1.42e-04 | 187 | 63 | 4 | 4d9ffd2bbdf1c9869e28991ce9331e4ccf3c0166 | |
| ToppCell | control-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.42e-04 | 187 | 63 | 4 | c78aee98b32719aa45811b620fc97be1ecf5fd53 | |
| ToppCell | (0)_Myeloid-(011)_pDC|(0)_Myeloid / immune cells in Peripheral Blood (logTPM normalization) | 1.45e-04 | 188 | 63 | 4 | a81b5d840490d6a636fe168f8cff2c4984369f09 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.45e-04 | 188 | 63 | 4 | 43a3a59f92ad93509d4166bd025aed0b1b39a008 | |
| ToppCell | COVID-19_Severe-pDC|World / disease group, cell group and cell class | 1.45e-04 | 188 | 63 | 4 | 4c8e328b8206120708b05ea3c5865a0200dc5c4e | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 1.45e-04 | 188 | 63 | 4 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs-Plasmacytoid_DCs_L.1.5.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.45e-04 | 188 | 63 | 4 | 1f820cb19eb0e15f0eb69d07e457072bbdad8ecb | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 1.45e-04 | 188 | 63 | 4 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_NK-NK_CD56bright_CD16-|bone_marrow / Manually curated celltypes from each tissue | 1.48e-04 | 189 | 63 | 4 | 6e402fb3fc31e4cb541e3cd140d7a86c1083dbf5 | |
| ToppCell | IPF-Epithelial-Club|IPF / Disease state, Lineage and Cell class | 1.48e-04 | 189 | 63 | 4 | f3fcef008ef252b29ac6d567fef27f9acf9cd70f | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 189 | 63 | 4 | 0739baad9a7da511dd3d7249f84299aee88370a1 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-04 | 190 | 63 | 4 | c44aae2e0d3cc84a187e12917fd8c2d7483f41d8 | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 1.51e-04 | 190 | 63 | 4 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Dendritic-plasmacytoid_dendritic_cell-Plasmacytoid_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.51e-04 | 190 | 63 | 4 | 705489ebbaf3d8e643498c3e507742114475fc55 | |
| ToppCell | myeloid-pDC|World / Lineage and Cell class | 1.51e-04 | 190 | 63 | 4 | 88c42779ce2f817d28e672d83f3f1158581edf73 | |
| ToppCell | COPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d | |
| ToppCell | Control-pDC-|Control / Disease condition and Cell class | 1.54e-04 | 191 | 63 | 4 | 1d7b0fae4d114d6db933c18b4eb2066ffa61356d | |
| ToppCell | Healthy-pDC|World / disease group, cell group and cell class | 1.54e-04 | 191 | 63 | 4 | 6e1d825dc33b915b95f13ccd237a552160a4be98 | |
| ToppCell | Control-pDC|Control / Disease condition and Cell class | 1.54e-04 | 191 | 63 | 4 | 543e1437a52d04436862dd1c27b4fae95c44fcc8 | |
| ToppCell | IPF-Epithelial-Club|World / Disease state, Lineage and Cell class | 1.54e-04 | 191 | 63 | 4 | 3c88a6f1d74bb3b9173cd0ea3a63c6d9570e3954 | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-04 | 192 | 63 | 4 | faead5875a54fe8f1848ae36008aae4c0f7cb1c7 | |
| ToppCell | proximal-3-Hematologic-Plasmacytoid_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-04 | 192 | 63 | 4 | 86938c7d2bb1a7afb2b83828ca33dd137d366ec6 | |
| ToppCell | Control-Multiplet-Multiplet|World / Disease state, Lineage and Cell class | 1.57e-04 | 192 | 63 | 4 | 1bfd022d5b87cf8a5d5069f559339a553a52a0a2 | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 1.57e-04 | 192 | 63 | 4 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | Healthy-pDC|Healthy / disease group, cell group and cell class | 1.57e-04 | 192 | 63 | 4 | 33d695a28d22b4af111df9591830a33bb7ef7b2d | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 1.57e-04 | 192 | 63 | 4 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | proximal-Hematologic-Plasmacytoid_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.57e-04 | 192 | 63 | 4 | e3be395a995dc8c0ebdae754057cfa59a270cae0 | |
| ToppCell | 11.5-Airway-Immune-Hematopoietic,_T_Cells|Airway / Age, Tissue, Lineage and Cell class | 1.60e-04 | 193 | 63 | 4 | 7c14bc481ed38378b9e6a85f768a1e526c5997e6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.60e-04 | 193 | 63 | 4 | a0ca3231992f14abcf1a6129573bace320e89d2a | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 194 | 63 | 4 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.64e-04 | 194 | 63 | 4 | 04bfc555743f7d8821439d05ae442d15e9886c59 | |
| ToppCell | LPS_only-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 194 | 63 | 4 | 58f069efdefa0366033764446b9d6ffd4a17807e | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.64e-04 | 194 | 63 | 4 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-04 | 194 | 63 | 4 | bfd92ec75facb0ba55c31e5f2e089d983b3d0169 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.64e-04 | 194 | 63 | 4 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | (0)_NK_cells-(0)_NK_CD160pos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.67e-04 | 195 | 63 | 4 | 6cbeceb52bb207f3c074e57b5b3f7cfb24fd5877 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.67e-04 | 195 | 63 | 4 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 1.67e-04 | 195 | 63 | 4 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-04 | 196 | 63 | 4 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.70e-04 | 196 | 63 | 4 | 3a8bd09a09c19df27c954d448f1bae945314c221 | |
| ToppCell | mild-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.74e-04 | 197 | 63 | 4 | 0cb00daa6943f7a7fb34a8fdf51188646af65686 | |
| ToppCell | 10x3'2.3-week_17-19|World / cell types per 3 fetal stages;per 3',per 5' | 1.74e-04 | 197 | 63 | 4 | f5cfad0b42d0f817e22cc78b9bfb2b4b7e4330ed | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.74e-04 | 197 | 63 | 4 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | mild-pDC|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.74e-04 | 197 | 63 | 4 | 15230a54fa5903dd728de1a0ad633bd2d2c7a04d | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.77e-04 | 198 | 63 | 4 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | severe-pDC|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-04 | 198 | 63 | 4 | 3c4820a8391088682fb3e47b914f872533bae227 | |
| ToppCell | severe-pDC|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.77e-04 | 198 | 63 | 4 | 22da4a29b9ff8b94d98bc69b4632a2a58d5dd9e6 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 1.80e-04 | 199 | 63 | 4 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | MS-IIF-Myeloid-pDC|IIF / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | e262ee854e64d87460bee810c14d6cbe744460e8 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 1.80e-04 | 199 | 63 | 4 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-04 | 199 | 63 | 4 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Control-Control-Myeloid-pDC|Control / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | 8e9cac53fabe497ffa27fca0627eafe883af2534 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 1.80e-04 | 199 | 63 | 4 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|megakaryocytic / Lineage and Cell class | 1.80e-04 | 199 | 63 | 4 | 99a65887d3c8a2cde26693dd74404b101bba9d58 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.80e-04 | 199 | 63 | 4 | 4366ead68736ae3a2cefac71fd349d526cccb611 | |
| ToppCell | Sepsis-URO-Myeloid-pDC|URO / Disease, condition lineage and cell class | 1.80e-04 | 199 | 63 | 4 | 1dc96a1cc313fa175fe50f0df606baa84ea5970b | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.84e-04 | 200 | 63 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.84e-04 | 200 | 63 | 4 | b340b6acf675c75adffb98e560080f966571f594 | |
| ToppCell | Tracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.84e-04 | 200 | 63 | 4 | d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e | |
| ToppCell | Biopsy_Other_PF-Epithelial-Transitional_AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 1.84e-04 | 200 | 63 | 4 | 1ba6327851aa61e9a1f1fe1671bc27929d93ac74 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.84e-04 | 200 | 63 | 4 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 5.60e-04 | 17 | 61 | 2 | C1839839 | |
| Disease | hemoglobin change measurement | 9.46e-04 | 22 | 61 | 2 | EFO_0600027 | |
| Disease | testosterone measurement | MAGI1 CEP68 SHROOM3 SLC22A8 TPRN ZBTB10 MYO15A SH2B1 ARHGEF15 | 1.17e-03 | 1275 | 61 | 9 | EFO_0004908 |
| Disease | Adenoid Cystic Carcinoma | 1.18e-03 | 100 | 61 | 3 | C0010606 | |
| Disease | monocyte count | KSR1 TMEM121B PIEZO1 YLPM1 MACROD1 DENND1C RUNX2 NOTCH4 MYBPC3 | 1.49e-03 | 1320 | 61 | 9 | EFO_0005091 |
| Disease | pyridoxate measurement | 1.88e-03 | 31 | 61 | 2 | EFO_0010527 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RSRGEGDGTYFARRG | 16 | Q9H8V8 | |
| GDGTYFARRGAGRRR | 21 | Q9H8V8 | |
| GGDASGLGRRRLSFQ | 256 | Q76N32 | |
| FSRIARVGFLSRGRG | 736 | C9J069 | |
| RVGFLSRGRGVLFLG | 741 | C9J069 | |
| RRLAGRFEGGAEGRA | 151 | O94989 | |
| LAGNRRFGFCRLRAG | 76 | Q8IV53 | |
| GFFGRRRFSGRPKLS | 146 | P51861 | |
| GRLGLLGRRGFSGRL | 161 | P51861 | |
| HRASFLGGRRRGGAL | 431 | Q6UXT9 | |
| EFARGFLGSLRGGRR | 66 | Q8IZ41 | |
| TAAAFRGAHLRGRGR | 276 | O43251 | |
| GARFALVREDRGGRR | 331 | P04217 | |
| ERGAKGFGFSLRGGR | 1156 | Q96QZ7 | |
| LRRMESGFGFRILGG | 781 | Q86UL8 | |
| RRRKFEFDLRGDRGG | 246 | O75420 | |
| EGIRAAYRRGDRGGA | 56 | Q38SD2 | |
| ALRGRGFGRRLMEGL | 146 | Q93015 | |
| RGSRRRGAAFGFPGA | 746 | Q9UKN7 | |
| FGVSGRFLRGRSSRG | 346 | Q9BX40 | |
| RFLRGRSSRGGFRGG | 351 | Q9BX40 | |
| RSNFRGERGGFRGGR | 431 | Q9HCE5 | |
| GRFFHDRRERRLGGL | 1586 | O60318 | |
| RGSLLLRRGFSDSGG | 56 | Q9H307 | |
| FGLFGISGVVREGRR | 751 | Q8IVT5 | |
| FFKGGRQGRLARDGR | 471 | Q9H5P4 | |
| LDVFSRTRGRGRGRG | 381 | Q9NQV6 | |
| DFFGNRRGPRGSRSR | 121 | O75190 | |
| LFRRFGRQRKIGGRG | 1006 | Q6WRI0 | |
| RDGLRERRGFSEGGR | 11 | Q8WVX3 | |
| RIRGRGRARGVFAGT | 801 | Q9NYF8 | |
| NYIHRIGRGGRFGRK | 356 | Q14240 | |
| AFLGVFGRRARTSAG | 46 | Q9BQ69 | |
| ILDSIGRFFGGDRGA | 171 | P02686 | |
| LRRFRAVFGESGGGG | 126 | Q03164 | |
| GGLVLGDLSDRFGRR | 136 | Q8TCC7 | |
| RVLRAAGGFGRARRL | 6 | A6NKX4 | |
| AHRGERRGIGGIFFD | 326 | P36551 | |
| EKRFDNRGGGGFRGR | 606 | Q9BUJ2 | |
| RFNDLRFVGRSGRGK | 181 | Q13950 | |
| RGRGTYDLDFRGRDG | 176 | P78332 | |
| HRFERLRLSRGGGAL | 226 | Q9NRF2 | |
| FFISDGRSRRRRGGG | 111 | Q9NQ03 | |
| FLRGGSFRGRRGSGD | 31 | Q9BXQ6 | |
| ILGGHLSDRFGRRFV | 161 | Q8IVM8 | |
| RFELRRGSGGRGRFR | 1161 | O14841 | |
| RGRFRGGDGVTRELL | 1171 | O14841 | |
| RGRGEYFARGRGFRG | 1026 | P48634 | |
| TYGGRGRGARSREFR | 1041 | P48634 | |
| ARFTARGGRVFTPRG | 1151 | P48634 | |
| SSSFAGGRRLGERRR | 1171 | Q8TF72 | |
| AVRGRGRGTLTRGAF | 606 | Q96SI9 | |
| RGRFIRDFSREGGGE | 966 | Q6P9B9 | |
| RGRYGVAAGRGGRVS | 1931 | Q99466 | |
| SRGGRGRGRYSDRFS | 76 | Q13243 | |
| EGGRFFPRERKRFRG | 256 | O75969 | |
| RREGRRQSFGGSLFA | 346 | Q99856 | |
| RGFFRGGRGRGRGFS | 101 | Q14011 | |
| RGTFQFRARGRGWGR | 831 | Q9Y2W1 | |
| GGFRRTFSRSERAGV | 361 | Q9NVW2 | |
| RGQARGRGRGFREFT | 1061 | Q5JSZ5 | |
| GRGRGFREFTFRGRP | 1066 | Q5JSZ5 | |
| QDGDFGSRLRGRGRR | 431 | O43290 | |
| GSRERGLGRSDFGRD | 1151 | P49750 | |
| GLGRSDFGRDRGPFR | 1156 | P49750 | |
| GGGAAGARLLERYRR | 71 | Q4KMQ1 | |
| AERNRRTLAFRGGGG | 116 | Q96DT7 | |
| SGGRVRAAGRRLQGF | 1916 | Q92508 | |
| RSFSKRLFRSGRAGG | 21 | Q70CQ4 | |
| LDRFRFRGRPYRGGS | 141 | O60293 | |
| RSDRRRGDDGGFFPR | 216 | O15321 | |
| RRYVRGRFLGKGGFA | 51 | P53350 | |
| FRRTSLAGGGRRISD | 271 | Q14896 | |
| RRAFIGIGFGDRGDA | 101 | Q9NVZ3 |